164 related articles for article (PubMed ID: 6364796)
41. [Changes in plasma insulin and growth hormone after intravenous glucagon in hepatic cirrhosis].
Ghirlanda G; Manna R; Rebuzzi A; Altomonte L; Greco AV
Minerva Med; 1976 Oct; 67(49):3187-92. PubMed ID: 995278
[TBL] [Abstract][Full Text] [Related]
42. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
Gerö L; Korányi L; Szalay F; Büki B; Tamás G
Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
[TBL] [Abstract][Full Text] [Related]
43. [Beta-cell activity during the oral glucose tolerance test in subjects with hepatic cirrhosis].
Stufano N; Altomare E; Romano A; Vendemiale G; Albano O
Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1127-32. PubMed ID: 6383429
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
45. Does a long pre-operative hospital stay before hepatectomy improve liver dysfunction in HCC patients with chronic liver disease?
Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):472-6. PubMed ID: 9164521
[TBL] [Abstract][Full Text] [Related]
46. Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery.
Alford FP; Dudley FJ; Chisholm DJ; Findlay DM
Clin Endocrinol (Oxf); 1979 Oct; 11(4):413-24. PubMed ID: 519879
[TBL] [Abstract][Full Text] [Related]
47. Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study.
Bassanello M; De Palo EF; Lancerin F; Vitale A; Gatti R; Montin U; Ciarleglio FA; Senzolo M; Burra P; Brolese A; Zanus G; D'Amico DF; Cillo U
Liver Transpl; 2004 May; 10(5):692-8. PubMed ID: 15108263
[TBL] [Abstract][Full Text] [Related]
48. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.
Klotz U; Antonin KH
Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401
[TBL] [Abstract][Full Text] [Related]
49. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
[TBL] [Abstract][Full Text] [Related]
50. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of insulin receptors in postnecrotic cirrhosis of liver.
Teng CS; Ho PW; Yeung RT
J Clin Endocrinol Metab; 1982 Sep; 55(3):524-30. PubMed ID: 6284782
[TBL] [Abstract][Full Text] [Related]
52. Effect of moderate exercise on insulin sensitivity and substrate metabolism during post-exercise recovery in cirrhosis.
Petrides AS; Matthews DE; Esser U
Hepatology; 1997 Oct; 26(4):972-9. PubMed ID: 9328322
[TBL] [Abstract][Full Text] [Related]
53. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
[TBL] [Abstract][Full Text] [Related]
54. Metabolic derangement of glucose, bile acid and amino acids after portasystemic shunts in cirrhotic rats.
Kuang YL; Chen ZP; Wu ZY; Huang A; Yuan JM; Zheng ZH; Xiao SD; Zeng MD
Chin Med J (Engl); 1989 Jun; 102(6):434-40. PubMed ID: 2512064
[TBL] [Abstract][Full Text] [Related]
55. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C
Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846
[No Abstract] [Full Text] [Related]
56. [Experimental study of orthotopic liver transplantation in dog--with reference to change of hepatic function, serum insulin, glucagon, c-AMP after liver transplantation and the viability of the graft].
Ohno Y
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1192-203. PubMed ID: 2847004
[TBL] [Abstract][Full Text] [Related]
57. Is hepatic glycogen content a regulator of glucagon secretion?
Kabadi UM
Metabolism; 1992 Feb; 41(2):113-5. PubMed ID: 1736031
[TBL] [Abstract][Full Text] [Related]
58. Impaired plasma cyclic AMP response to exogenous glucagon in acute liver injury.
Miyakoshi H; Noda Y; Uchida S; Tanaka N; Noto Y; Kato Y; Kawai K; Hayakawa H; Kobayashi K; Hattori N
J Clin Gastroenterol; 1984 Aug; 6(4):337-42. PubMed ID: 6090530
[TBL] [Abstract][Full Text] [Related]
59. [Evaluation of liver function by means of the glucagon test].
Brunner H; Grabner G; Michalek P; Paumgartner G
Wien Z Inn Med; 1968; 49(11):409-17. PubMed ID: 5737590
[No Abstract] [Full Text] [Related]
60. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
Gragnoli G; Signorini AM; Tanganelli I
J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
